Login / Signup

A nitrosyl iron complex with 3.4-dichlorothiophenolyl ligands: synthesis, structures and its reactions with targets - carriers of nitrogen oxide (NO) in vivo .

Olesya V PokidovaVeronika O NovikovaNina S Emel'yanovaAlexandra Yu KormukhinaAlexander V KulikovAndrey N UtenyshevVladimir A LazarenkoNikolai S OvanesyanArina A StarostinaNataliya A Sanina
Published in: Dalton transactions (Cambridge, England : 2003) (2023)
In this work, a new binuclear nitrosyl complex with 3.4-dichlorothiophenolyl ligands [Fe 2 (SC 6 H 3 Cl 2 ) 2 (NO) 4 ] has been synthesized. Nitrosyl iron complexes (NICs) are systems for the storage and delivery of NO in the body. There is a dynamic equilibrium between dinitrosyl iron units bound to low molecular weight ligands and high molecular weight (protein) ligands in vivo . From this point of view, the transformation of the studied complex in DMSO and buffer, as well as in biological systems, has been analyzed. In DMSO, it decomposes into mononuclear NICs, which quickly decay in buffer solutions with NO release. The high molecular weight product is formed as a result of the binding of the complex to bovine serum albumin (the Stern-Volmer constant is 2.1 × 10 5 M -1 ). In this case, the complex becomes a prolonged NO-donor. Such a long-term effect has been observed for the first time. Similarly, in a system with oxyhemoglobin, NO generation is slower; the UV-vis spectra show a gradual formation of methemoglobin. On the other hand, reduced glutathione has little effect on the NO-donor properties of the complex despite the fact that ligand substitution is observed in the system and a binuclear product is formed. Mucin binds the complex, and the decomposition mechanism is different from that for buffer solutions. Thus, these proteins and glutathione are able to participate in the transformation of the complex and modulate its properties as a potential drug.
Keyphrases
  • high resolution
  • transcription factor
  • mass spectrometry
  • risk assessment
  • small molecule